Mobix Labs Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

About this update from Mobix Labs, Inc.

[{"type":"text","content":"IRVINE, Calif., April 04, 2025--(BUSINESS WIRE)--Mobix Labs, Inc. (Nasdaq: MOBX, "Mobix Labs" or the "Company"), a leading provider of advanced connectivity solutions, today announced that it has entered into a definitive agreement with institutional investors for the purchase and sale of an aggregate of 4,876,860 shares of the Company’s Class A common stock (the "common stock") (or common stock equivalents in lieu thereof) at a purchase price of $0.8202 per share of common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered common stock purchase warrants. The common stock purchase warrants to purchase up to 4,876,860 shares of common stock have an exercise price of $0.8202 per share, are exercisable after stockholder approval, and expire 5 years after stockholder approval. The offering is expected to close on or about April 7, 2025, subject to the satisfaction of customary closing conditions.","length":1093,"tagName":"p"},{"type":"text","content":"Roth Capital Partners is acting as the exclusive placement agent for the offering.","length":82,"tagName":"p"},{"type":"text","content":"The gross proceeds to the Company from the offering are expected to be $4.0 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes.","length":300,"tagName":"p"},{"type":"text","content":"The shares of common stock (or common stock equivalents in lieu thereof) are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-284351) previously filed with the Securities and Exchange Commission (the "SEC") and declared effective by the SEC on January 24, 2025. The offering of these securities is made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained, when available, on the...

More updates from Mobix Labs, Inc.